"Naloxone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.
| Descriptor ID |
D009270
|
| MeSH Number(s) |
D03.132.577.249.706 D03.605.497.750 D03.633.400.686.750 D04.615.723.795.706
|
| Concept/Terms |
MRZ-2593- MRZ-2593
- MRZ 2593
- MRZ2593
- MRZ 2593-Br
- MRZ 2593 Br
- MRZ 2593Br
|
Below are MeSH descriptors whose meaning is more general than "Naloxone".
Below are MeSH descriptors whose meaning is more specific than "Naloxone".
This graph shows the total number of publications written about "Naloxone" by people in this website by year, and whether "Naloxone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 1 | 1 |
| 2017 | 6 | 7 | 13 |
| 2018 | 3 | 5 | 8 |
| 2019 | 2 | 2 | 4 |
| 2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Naloxone" by people in Profiles.
-
Development, implementation, and evaluation of a clinical decision support tool to improve naloxone coprescription within Military Health System pharmacies. Am J Health Syst Pharm. 2022 Jan 01; 79(1):e58-e64.
-
Willingness to use a wearable device capable of detecting and reversing overdose among people who use opioids in Philadelphia. Harm Reduct J. 2021 07 23; 18(1):75.
-
Polysubstance use trends and variability among individuals with opioid use disorder in rural versus urban settings. Prev Med. 2021 11; 152(Pt 2):106729.
-
Cost-effectiveness of Treatments for Opioid Use Disorder. JAMA Psychiatry. 2021 07 01; 78(7):767-777.
-
Saving Lives: The Veterans Health Administration (VHA) Rapid Naloxone Initiative. Jt Comm J Qual Patient Saf. 2021 08; 47(8):469-480.
-
Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond. Am J Public Health. 2021 06; 111(6):1013-1017.
-
Increases in Naloxone Administrations by Emergency Medical Services Providers During the COVID-19 Pandemic: Retrospective Time Series Study. JMIR Public Health Surveill. 2021 05 27; 7(5):e29298.
-
Harm Reduction for Adolescents and Young Adults During the COVID-19 Pandemic: A Case Study of Community Care in Reach. Public Health Rep. 2021 05; 136(3):301-308.
-
A free mailed naloxone program in Philadelphia amidst the COVID-19 pandemic. Int J Drug Policy. 2021 08; 94:103199.
-
Adapting harm reduction services during COVID-19: lessons from the supervised injecting facilities in Australia. Harm Reduct J. 2021 02 17; 18(1):20.